唾液外泌体miRNAs在头颈部鳞状细胞癌中的研究进展

何锦怡; 杨柳

doi:10.13201/j.issn.2096-7993.2024.03.016

唾液外泌体miRNAs在头颈部鳞状细胞癌中的研究进展

何锦怡¹,
杨柳^2, ,

- 1.
  四川大学华西临床医学院(成都，610041)
- 2.
  四川大学华西医院耳鼻咽喉头颈外科

详细信息

通讯作者: 杨柳，E-mail：yangliuent@163.com

中图分类号: R739.91

收稿日期: 2022-11-23

刊出日期: 2024-03-03

Advances in salivary exosomal miRNAs in head and neck squamous carcinoma

HE Jinyi¹,
YANG Liu^2, ,

- 1.
  West China School of Clinical Medicine, Sichuan University, Chengdu, 610041, China
- 2.
  Department of Otolaryngology Head & Neck Surgery, West China Hospital, Sichuan University

More Information

Corresponding author: YANG Liu, E-mail: yangliuent@163.com

Received Date: 23 November 2022

Publish Date: 03 March 2024

摘要

摘要: 唾液外泌体是指存在于唾液中的直径为30~150 nm的细胞外囊泡，在细胞之间的物质交换和信号转导方面发挥重要作用，能将其携带的脂质、蛋白质、核酸传递至受体细胞，调节受体细胞的生理、病理过程。miRNA作为外泌体中重要的“货物”被转运至受体细胞，调控受体细胞信号通路，从而对疾病的进展起着调节的作用。随着近年来技术手段的发展，大量研究揭示了唾液外泌体miRNA在头颈鳞癌的发生发展中发挥重要作用以及唾液外泌体miRNA在头颈鳞癌的诊断与治疗作用。本文综述了唾液外泌体miRNA在头颈鳞癌中的发生、治疗和预后，并讨论唾液外泌体miRNA作为生物标志物在头颈鳞癌诊断中的潜在前景和重要意义。
- 细胞外囊泡 /
- 唾液外泌体 /
- 生物标志物 /
- 头颈部鳞状细胞肿瘤
Abstract: Salivary exosomes are extracellular vesicles of 30-150 nm in diameter that exist in saliva and play an important role in substance exchange and signal transduction between cells, delivering the lipids, proteins and nucleic acids they carry to the recipient cells and regulating the physiological and pathological processes of the recipient cells. miRNA, as an important "cargo" in exosomes, is transported to the recipient cells and regulates the signaling pathways of the recipient cells, thus playing a regulatory role in disease progression. The miRNAs are transported to the recipient cells and regulate the signaling pathways of the recipient cells, thus playing a regulatory role in the progression of diseases. With the development of technological tools this year, numerous studies have revealed the important role of salivary exosomal miRNAs in the development of head and neck squamous carcinoma and the role of salivary exosomal miRNAs in the diagnosis and treatment of head and neck squamous carcinoma. This paper reviews the occurrence, treatment and prognosis of salivary exosomal miRNA in head and neck squamous carcinoma, and discusses the potential prospects and importance of salivary exosomal miRNA as a biomarker in the diagnosis of head and neck squamous carcinoma.
- extracellular vesicles /
- salivary exosomes /
- biomarkers /
- head and neck squamous carcinoma

HTML全文

参考文献(47)

[1]	EL Andaloussi S, Mäger I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities[J]. Nat Rev Drug Discov, 2013, 12(5): 347-357. doi: 10.1038/nrd3978
[2]	Sadri Nahand J, Moghoofei M, Salmaninejad A, et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review[J]. Int J Cancer, 2020, 146(2): 305-320. doi: 10.1002/ijc.32688
[3]	He T, Guo X, Li X, et al. Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma[J]. J Oncol, 2021, 2021: 5547911.
[4]	Zhao Q, Zheng X, Guo H, et al. Serum Exosomal miR-941 as a promising Oncogenic Biomarker for Laryngeal Squamous Cell Carcinoma[J]. J Cancer, 2020, 11(18): 5329-5344. doi: 10.7150/jca.45394
[5]	Chai RC, Lim Y, Frazer IH, et al. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a)expression in head and neck squamous cell carcinoma patients[J]. BMC Cancer, 2016, 16: 178. doi: 10.1186/s12885-016-2217-1
[6]	Nair S, Tang KD, Kenny L, et al. Salivary exosomes as potential biomarkers in cancer[J]. Oral Oncol, 2018, 84: 31-40. doi: 10.1016/j.oraloncology.2018.07.001
[7]	He L, Ping F, Fan Z, et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening[J]. Biomed Pharmacother, 2020, 121: 109553. doi: 10.1016/j.biopha.2019.109553
[8]	Zlotogorski-Hurvitz A, Dayan D, Chaushu G, et al. Human saliva-derived exosomes: comparing methods of isolation[J]. J Histochem Cytochem, 2015, 63(3): 181-189. doi: 10.1369/0022155414564219
[9]	Pedersen A, Sørensen CE, Proctor GB, et al. Salivary secretion in health and disease[J]. J Oral Rehabil, 2018, 45(9): 730-746. doi: 10.1111/joor.12664
[10]	Batista T, Chaiben CL, Penteado C, et al. Salivary proteome characterization of alcohol and tobacco dependents[J]. Drug Alcohol Depend, 2019, 204: 107510. doi: 10.1016/j.drugalcdep.2019.06.013
[11]	Corsello T, Kudlicki AS, Garofalo RP, et al. Cigarette Smoke Condensate Exposure Changes RNA Content of Extracellular Vesicles Released from Small Airway Epithelial Cells[J]. Cells, 2019, 8(12): 1652. doi: 10.3390/cells8121652
[12]	Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes[J]. PLoS One, 2012, 7(3): e30679. doi: 10.1371/journal.pone.0030679
[13]	Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy[J]. Mol Cancer, 2022, 21(1): 56. doi: 10.1186/s12943-022-01509-9
[14]	Silva J, Garcia V, Rodriguez M, et al. Analysis of exosome release and its prognostic value in human colorectal cancer[J]. Genes Chromosomes Cancer, 2012, 51(4): 409-418. doi: 10.1002/gcc.21926
[15]	Li YY, Tao YW, Gao S, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p[J]. EBioMedicine, 2018, 36: 209-220. doi: 10.1016/j.ebiom.2018.09.006
[16]	Sun LP, Xu K, Cui J, et al. Cancer associated fibroblast derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma[J]. Oncol Rep, 2019, 42(4): 1319-1328.
[17]	Zhu G, Cao B, Liang X, et al. Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma[J]. Cancer Lett, 2021, 506: 11-22. doi: 10.1016/j.canlet.2021.01.006
[18]	Momen-Heravi F, Bala S. Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway[J]. Oncotarget, 2018, 9(78): 34838-34854. doi: 10.18632/oncotarget.26208
[19]	Salazar-Ruales C, Arguello JV, López-Cortés A, et al. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population[J]. Biomed Res Int, 2018, 2018: 9792730.
[20]	Guo L, Guo N. Exosomes: Potent regulators of tumor malignancy and potential bio-tools in clinical application[J]. Crit Rev Oncol Hematol, 2015, 95(3): 346-358. doi: 10.1016/j.critrevonc.2015.04.002
[21]	Lu J, Liu QH, Wang F, et al. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma[J]. J Exp Clin Cancer Res, 2018, 37(1): 147. doi: 10.1186/s13046-018-0814-3
[22]	Hofmann L, Medyany V, Ezić J, et al. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer[J]. Front Med(Lausanne), 2022, 9: 904295.
[23]	Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, et al. Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts[J]. Sci Rep, 2017, 7(1): 17785. doi: 10.1038/s41598-017-18138-8
[24]	Liu CJ, Lin SC, Yang CC, et al. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma[J]. Head Neck, 2012, 34(2): 219-224. doi: 10.1002/hed.21713
[25]	Lu WC, Liu CJ, Tu HF, et al. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma[J]. Oncotarget, 2016, 7(35): 57254-57267. doi: 10.18632/oncotarget.11138
[26]	Mehterov N, Vladimirov B, Sacconi A, et al. Salivary miR-30c-5p as Potential Biomarker for Detection of Oral Squamous Cell Carcinoma[J]. Biomedicines, 2021, 9(9): 1079. doi: 10.3390/biomedicines9091079
[27]	Scholtz B, Horváth J, Tar I, et al. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma[J]. Pathogens, 2022, 11(2): 229. doi: 10.3390/pathogens11020229
[28]	Peng HY, Jiang SS, Hsiao JR, et al. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma[J]. Mol Oncol, 2016, 10(6): 895-909. doi: 10.1016/j.molonc.2016.03.001
[29]	Zhou X, Ren Y, Liu A, et al. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo[J]. Oncol Rep, 2014, 31(5): 2173-2180. doi: 10.3892/or.2014.3114
[30]	Harmati M, Tarnai Z, Decsi G, et al. Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells[J]. J Oral Pathol Med, 2017, 46(4): 259-266. doi: 10.1111/jop.12486
[31]	Zahran F, Ghalwash D, Shaker O, et al. Salivary microRNAs in oral cancer[J]. Oral Dis, 2015, 21(6): 739-747. doi: 10.1111/odi.12340
[32]	Maheswari T, Venugopal A, Sureshbabu NM, et al. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review[J]. Ci Ji Yi Xue Za Zhi, 2018, 30(2): 55-60.
[33]	Muhammad jawad khan AZ, Ghulam rabia SAA, Shanza sahar SB, et al. Role of salivary miRNAs and their target genes in oral cancer patients as a potential diagnostic tool[G]. Proceedings of the Annual Meeting of the American Association for Cancer Research. 2020: 80.
[34]	Duz MB, Karatas OF, Guzel E, et al. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study[J]. Cell Oncol(Dordr), 2016, 39(2): 187-193. doi: 10.1007/s13402-015-0259-z
[35]	Gu Y, Tang S, Wang Z, et al. Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma[J]. J Dent Sci, 2022, 17(2): 666-676. doi: 10.1016/j.jds.2021.08.016
[36]	Yang Y, Li YX, Yang X, et al. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis[J]. BMC Cancer, 2013, 13: 129. doi: 10.1186/1471-2407-13-129
[37]	Momen-Heravi F, Trachtenberg AJ, Kuo WP, et al. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer[J]. J Dent Res, 2014, 93(7 Suppl): 86S-93S.
[38]	Wu L, Zheng K, Yan C, et al. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma[J]. BMC Cancer, 2019, 19(1): 843. doi: 10.1186/s12885-019-6037-y
[39]	Ye SB, Li ZL, Luo DH, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma[J]. Oncotarget, 2014, 5(14): 5439-5452. doi: 10.18632/oncotarget.2118
[40]	Lin Z, Swan K, Zhang X, et al. Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells[J]. J Virol, 2016, 90(7): 3469-3479. doi: 10.1128/JVI.02830-15
[41]	Peacock B, Rigby A, Bradford J, et al. Extracellular vesicle microRNA cargo is correlated with HPV status in oropharyngeal carcinoma[J]. J Oral Pathol Med, 2018, 47(10): 954-963 doi: 10.1111/jop.12781
[42]	Lee JC, Zhao JT, Gundara J, et al. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222[J]. J Surg Res, 2015, 196(1): 39-48. doi: 10.1016/j.jss.2015.02.027
[43]	Wang J, Zhou Y, Lu J, et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma[J]. Med Oncol, 2014, 31(9): 148. doi: 10.1007/s12032-014-0148-8
[44]	Gao Q, Liu HT, Xu YQ, et al. Serum-derived exosomes promote CD8⁺T cells to overexpress PD-1, affecting the prognosis of hypopharyngeal carcinoma[J]. Cancer Cell Int, 2021, 21(1): 584. doi: 10.1186/s12935-021-02294-z
[45]	Ludwig S, Sharma P, Wise P, et al. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer[J]. Int J Mol Sci, 2020, 21(22): 8570. doi: 10.3390/ijms21228570
[46]	Brunner TF, Probst FA, Troeltzsch M, et al. Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study[J]. Head Face Med, 2022, 18(1): 21. doi: 10.1186/s13005-022-00322-5
[47]	Liu T, Chen G, Sun D, et al. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma[J]. Acta Biochim Biophys Sin(Shanghai), 2017, 49(9): 808-816.